These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27747870)

  • 1. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.
    Coothankandaswamy V; Cao S; Xu Y; Prasad PD; Singh PK; Reynolds CP; Yang S; Ogura J; Ganapathy V; Bhutia YD
    Br J Pharmacol; 2016 Dec; 173(23):3292-3306. PubMed ID: 27747870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.
    Karunakaran S; Ramachandran S; Coothankandaswamy V; Elangovan S; Babu E; Periyasamy-Thandavan S; Gurav A; Gnanaprakasam JP; Singh N; Schoenlein PV; Prasad PD; Thangaraju M; Ganapathy V
    J Biol Chem; 2011 Sep; 286(36):31830-8. PubMed ID: 21771784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.
    Karunakaran S; Umapathy NS; Thangaraju M; Hatanaka T; Itagaki S; Munn DH; Prasad PD; Ganapathy V
    Biochem J; 2008 Sep; 414(3):343-55. PubMed ID: 18522536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreatic cancer cells.
    Cai A; Zheng H; Chen Z; Lin X; Li C; Yao Q; Bhutia YD; Ganapathy V; Chen R; Kou L
    Biochem J; 2020 May; 477(10):1923-1937. PubMed ID: 32379301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.
    Sikder MOF; Sivaprakasam S; Brown TP; Thangaraju M; Bhutia YD; Ganapathy V
    Biochem J; 2020 Apr; 477(8):1409-1425. PubMed ID: 32219372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer.
    Schniers BK; Wachtel MS; Sharma M; Korac K; Rajasekaran D; Yang S; Sniegowski T; Ganapathy V; Bhutia YD
    Biochem J; 2022 Mar; 479(5):719-730. PubMed ID: 35212370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer.
    Babu E; Bhutia YD; Ramachandran S; Gnanaprakasam JP; Prasad PD; Thangaraju M; Ganapathy V
    Biochem J; 2015 Jul; 469(1):17-23. PubMed ID: 26173258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer.
    Lu Y; Jiang Z; Wang K; Yu S; Hao C; Ma Z; Fu X; Qin MQ; Xu Z; Fan L
    BMC Cancer; 2022 Jul; 22(1):833. PubMed ID: 35907820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC6A14 Depletion Contributes to Amino Acid Starvation to Suppress EMT-Induced Metastasis in Gastric Cancer by Perturbing the PI3K/AKT/mTORC1 Pathway.
    Guo Q; Xu W; Li X; Sun JL; Gu XC; Jing FB
    Biomed Res Int; 2022; 2022():7850658. PubMed ID: 35865664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEPT1 is essential for the growth of pancreatic cancer cells: a viable drug target.
    Schniers BK; Rajasekaran D; Korac K; Sniegowski T; Ganapathy V; Bhutia YD
    Biochem J; 2021 Oct; 478(20):3757-3774. PubMed ID: 34569600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
    Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma.
    Penheiter AR; Erdogan S; Murphy SJ; Hart SN; Felipe Lima J; Rakhshan Rohakhtar F; O'Brien DR; Bamlet WR; Wuertz RE; Smyrk TC; Couch FJ; Vasmatzis G; Bender CE; Carlson SK
    Biomed Res Int; 2015; 2015():593572. PubMed ID: 26106611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14.
    McCracken AN; Edinger AL
    Biochem J; 2015 Sep; 470(3):e17-9. PubMed ID: 26341486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
    Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
    Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
    Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure.
    Palazzolo L; Paravicini C; Laurenzi T; Adobati S; Saporiti S; Guerrini U; Gianazza E; Indiveri C; Anderson CMH; Thwaites DT; Eberini I
    SLAS Discov; 2019 Oct; 24(9):928-938. PubMed ID: 31373846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of SLC6A14 trafficking in breast cancer cells by heat shock protein HSP90β.
    Połosak K; Papierniak-Wyglądała A; Nałęcz KA
    Biochem Biophys Res Commun; 2022 Jul; 614():41-46. PubMed ID: 35569376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trafficking to the Cell Surface of Amino Acid Transporter SLC6A14 Upregulated in Cancer Is Controlled by Phosphorylation of SEC24C Protein by AKT Kinase.
    Kovalchuk V; Nałęcz KA
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
    Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
    Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino Acid Transporter SLC6A14 (ATB
    Nałęcz KA
    Front Cell Dev Biol; 2020; 8():594464. PubMed ID: 33195271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.